Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non-invasive diagnosis for urothelial carcinoma using a dual-target DNA methylation biomarker panel

26 Jan 2025

Abstract excerpt

BACKGROUND: Urothelial carcinoma (UC) is a common malignancy worldwide. Aberrant DNA methylation is implicated in UC carcinogenesis. This study sought to delineate the DNA methylation landscape in UC and identify DNA methylation-based biomarkers for early detection of UC. METHODS: Whole genome bisulfite sequencing (WGBS) was conducted on bladder cancer tissues and paired normal tissues. By integrating WGBS data...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39875053
DOI: 10.1016/j.cca.2025.120164

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non-invasive diagnosis for urothelial carcinoma using a dual-target DNA methylation biomarker panelPMID 39875053Read ↗

Diagnostic markers of urothelial cancer based on DNA methylation analysisSemantic proximity Read ↗

Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancerSemantic proximity Read ↗

A novel and sensitive DNA methylation marker for the urine-based liquid biopsies to detect bladder cancerSemantic proximity Read ↗

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity Read ↗

Roles for epigenetic and other biomarkers in upper tract urothelial carcinoma diagnosis and surveillanceSemantic proximity Read ↗

Methylcap-Seq Reveals Novel DNA Methylation Markers for the Diagnosis and Recurrence Prediction of Bladder Cancer in a Chinese PopulationSemantic proximity Read ↗

MicroRNA promoter methylation: a new tool for accurate detection of urothelial carcinomaSemantic proximity Read ↗

Bladder cancer detection in urine by novel methylation markersSemantic proximity Read ↗

UroMark—a urinary biomarker assay for the detection of bladder cancerSemantic proximity Read ↗

Clinical Utility of Urine DNA for Noninvasive Detection and Minimal Residual Disease Monitoring in Urothelial CarcinomaSemantic proximity Read ↗

BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patientsSemantic proximity Read ↗

A Two-Gene Methylation Signature for the Diagnosis of Bladder Cancer in UrineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.